ArticleCureus2025
Robot-Assisted Multiquadrant Operation: Proctocolectomy and Abdominoperineal Resection Using the Da Vinci Xi for Familial Adenomatous Polyposis With Rectal Carcinoma.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Familial adenomatous polyposis (FAP) is a rare inherited disorder that is characterized by the formation of multiple adenomatous polyps in the colon that are precancerous. Diagnosis of the disease is of utmost importance in patients with a history of FAP, and prophylactic fibrocolonoscopies should be performed as early as the teenage years. This rare but significant genetic condition usually manifests in late adolescence or early adult years. The clinical case highlights the importance of a multidisciplinary approach and the need for early diagnosis and treatment in patients with FAP. The da Vinci Xi robotic system (Intuitive Surgical, CA, USA) has been successfully applied in multiquadrant operations such as total colectomy with abdominoperineal extirpation of the rectum. We present the case of a 38-year-old man admitted to our clinic, the First Clinic of Surgery in University Hospital Saint Marina, Varna, Bulgaria, in late 2022 with complaints of blood in stool and abnormal defecation rhythm. The fibrocolonoscopy found a tumor formation at 4 cm of the anorectal junction, a second tumor formation at 10 cm, and multiple colonic polyposis. Biopsies taken from the suspected areas confirmed the presence of two rectal carcinomas and adenomatous polyposis in the remaining areas. Neoadjuvant radiotherapy and chemotherapy with capecitabine 1600 mg were performed. Persistent carcinoma was an indication for performing robot-assisted proctocolectomy combined with abdominoperineal resection of the rectum. The robotic platform we used was the da Vinci Xi, a single-docking patient platform with three boom repositioning. The patient was followed for 24 months postoperatively. Recovery was uneventful, with no major complications. The terminal ileostomy functioned well, and the patient adapted successfully to stoma care. During follow-up, no local or systemic recurrence of the oncological disease was observed, and surveillance imaging remained clear throughout the period. This clinical case provides an important example of the multidisciplinary approach in the diagnosis and treatment of FAP. Neoadjuvant therapy, including radiotherapy and chemotherapy followed by robot-assisted surgery, demonstrates the significant potential of modern treatment approaches. Robot-assisted proctocolectomy is a relatively new approach whose advantages and disadvantages are yet to be explored. Collaboration between gastroenterologists, oncologists, radiologists, and surgeons is essential for the comprehensive management of such complex cases. Finally, this clinical case highlights the need for long-term surveillance of patients with FAP for early detection and management of potential recurrences or new disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.